Catherine Shaffer is a contributing writer to BioPharm International, cathshaffer@gmail.com.
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.
Ensuring the Biological Integrity of Raw Materials
A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.